Heartflow vs iRhythm
HTFL and IRTC side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HTFL and IRTC compare
Heartflow is the larger company, worth 1.4 times as much as iRhythm ($4.2B against $3.0B).
Heartflow grew revenue faster over the last twelve months (47.4% versus 21.6% for iRhythm).
iRhythm keeps more of each dollar of sales as profit, with a net margin of −4.5% compared with −33.1% at Heartflow.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HTFL | IRTC |
|---|---|---|
| Size and price | ||
| Market cap | $4.2B | $3.0B |
| Share price | $48.46 | $91.91 |
| Change, 1 year | 35.6% | −48.7% |
| Change, 5 years | – | −8.3% |
| Beta (5Y) | 1.70 | 1.20 |
| Employees | 843 | 2,400 |
| StockData Score | ||
| Total score | 9 | 9 |
| Valuation score | 0 | 1 (better) |
| Growth score | 3 | 4 (better) |
| Performance score | 1 | 3 (better) |
| Health score | 5 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 17.7× | 3.5× (better) |
| P/B | 14.9× (better) | 17.1× |
| P/FCF | – | 410× |
| FCF yield | −1.3% | 0.24% (better) |
| Fair value | $9.03 | $92.79 |
| Margin of safety | −437% | 0.95% (better) |
| Growth | ||
| Revenue growth (TTM) | 47.4% (better) | 21.6% |
| Revenue growth, 5Y average | – | 23.0% |
| Profitability | ||
| Gross margin | 81.8% (better) | 72.3% |
| Operating margin | −33.1% | −5.7% (better) |
| Net margin | −33.1% | −4.5% (better) |
| FCF margin | −23.5% | 0.86% (better) |
| Return on equity | −29.4% | −25.8% (better) |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | −4937.5× | −3.7× (better) |
| Current ratio | 4.41 (better) | 3.57 |
| Altman Z-score | 30.78 (better) | 2.11 |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 86.0% | 108% |
| Held by insiders | 58.7% | 2.1% |
| Insider net buying, 12 months | −$143M | −$24.4M (better) |
| Short interest, % of float | 15.9% | 10.1% |
Go deeper
- HTFL stock overview
- HTFL income statement
- HTFL valuation and score
- IRTC stock overview
- IRTC income statement
- IRTC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.